CD44 and hepatoblastoma: Another miRNA, miR-492, was studied by Frowein et al. The non-kinase transmembrane glycoprotein CD44 is a target of miR-492, which can act directly on the CD44 target to affect the ability of Hepatoblastoma cells to proliferate and metastasize.